Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Clinical trial NCT00486356 · COMPLETED

Trial details

NCT number: NCT00486356
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Extrahepatic Bile Duct Cancer Gallbladder Cancer Gastric Cancer Liver Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-10-01
Primary completion: 2010-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.